1. Home
  2. VCEL vs PFS Comparison

VCEL vs PFS Comparison

Compare VCEL & PFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCEL
  • PFS
  • Stock Information
  • Founded
  • VCEL 1989
  • PFS 1839
  • Country
  • VCEL United States
  • PFS United States
  • Employees
  • VCEL N/A
  • PFS N/A
  • Industry
  • VCEL Biotechnology: Biological Products (No Diagnostic Substances)
  • PFS Savings Institutions
  • Sector
  • VCEL Health Care
  • PFS Finance
  • Exchange
  • VCEL Nasdaq
  • PFS Nasdaq
  • Market Cap
  • VCEL 2.1B
  • PFS 2.2B
  • IPO Year
  • VCEL 1997
  • PFS N/A
  • Fundamental
  • Price
  • VCEL $41.83
  • PFS $18.07
  • Analyst Decision
  • VCEL Strong Buy
  • PFS Strong Buy
  • Analyst Count
  • VCEL 8
  • PFS 5
  • Target Price
  • VCEL $62.00
  • PFS $23.60
  • AVG Volume (30 Days)
  • VCEL 430.3K
  • PFS 677.0K
  • Earning Date
  • VCEL 07-31-2025
  • PFS 07-24-2025
  • Dividend Yield
  • VCEL N/A
  • PFS 5.27%
  • EPS Growth
  • VCEL 521.85
  • PFS N/A
  • EPS
  • VCEL 0.05
  • PFS 1.19
  • Revenue
  • VCEL $238,541,000.00
  • PFS $700,486,000.00
  • Revenue This Year
  • VCEL $23.03
  • PFS $26.03
  • Revenue Next Year
  • VCEL $24.52
  • PFS $7.82
  • P/E Ratio
  • VCEL $805.02
  • PFS $15.33
  • Revenue Growth
  • VCEL 14.80
  • PFS 58.68
  • 52 Week Low
  • VCEL $37.39
  • PFS $14.14
  • 52 Week High
  • VCEL $63.00
  • PFS $22.24
  • Technical
  • Relative Strength Index (RSI)
  • VCEL 47.28
  • PFS 58.76
  • Support Level
  • VCEL $40.53
  • PFS $16.73
  • Resistance Level
  • VCEL $43.57
  • PFS $18.00
  • Average True Range (ATR)
  • VCEL 1.67
  • PFS 0.39
  • MACD
  • VCEL -0.10
  • PFS 0.13
  • Stochastic Oscillator
  • VCEL 27.68
  • PFS 77.16

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

About PFS Provident Financial Services Inc

Provident Financial Services Inc is the holding company for The Provident Bank, a community-oriented bank. The Company's operations are solely in the financial services industry and include providing traditional banking and other financial services to its customers. The Company operates in the geographical regions of northern and central New Jersey, Queens and Nassau Counties in New York and eastern Pennsylvania. The Company has a single reporting segment for financial reporting purposes. The majority of the revenue-generating activities that are components of non-interest income are These revenue streams can generally be classified into three broad categories: wealth management revenue, insurance agency income, and banking service charges and other fees.

Share on Social Networks: